American Portfolios Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.73M | Buy |
52,651
+218
| +0.4% | +$7.17K | 0.07% | 273 |
|
|
2022
Q2 | $1.65M | Sell |
52,433
-2,692
| -5% | -$84.8K | 0.07% | 287 |
|
|
2022
Q1 | $2.53M | Sell |
55,125
-2,602
| -5% | -$120K | 0.09% | 243 |
|
|
2021
Q4 | $3.54M | Sell |
57,727
-1,964
| -3% | -$120K | 0.12% | 171 |
|
|
2021
Q3 | $4.46M | Sell |
59,691
-6,225
| -9% | -$465K | 0.17% | 114 |
|
|
2021
Q2 | $6.1M | Sell |
65,916
-1,804
| -3% | -$167K | 0.24% | 79 |
|
|
2021
Q1 | $6.01M | Buy |
67,720
+8,351
| +14% | +$741K | 0.26% | 75 |
|
|
2020
Q4 | $5.54M | Buy |
59,369
+5,402
| +10% | +$504K | 0.28% | 64 |
|
|
2020
Q3 | $3.44M | Sell |
53,967
-27,306
| -34% | -$1.74M | 0.2% | 102 |
|
|
2020
Q2 | $4.24M | Buy |
81,273
+66,308
| +443% | +$3.46M | 0.28% | 73 |
|
|
2020
Q1 | $468K | Buy |
14,965
+4,012
| +37% | +$125K | 0.04% | 385 |
|
|
2019
Q4 | $367K | Buy |
10,953
+1,609
| +17% | +$53.9K | 0.03% | 529 |
|
|
2019
Q3 | $276K | Buy |
9,344
+3,744
| +67% | +$111K | 0.02% | 586 |
|
|
2019
Q2 | $193K | Buy |
5,600
+1,526
| +37% | +$52.6K | 0.02% | 724 |
|
|
2019
Q1 | $134K | Buy |
4,074
+851
| +26% | +$28K | 0.01% | 765 |
|
|
2018
Q4 | $77.3K | Sell |
3,223
-1,228
| -28% | -$29.4K | 0.01% | 838 |
|
|
2018
Q3 | $149K | Buy |
4,451
+2,040
| +85% | +$68.2K | 0.02% | 684 |
|
|
2018
Q2 | $70.1K | Buy |
2,411
+100
| +4% | +$2.91K | 0.01% | 951 |
|
|
2018
Q1 | $59.5K | Buy |
2,311
+1,311
| +131% | +$33.8K | 0.01% | 945 |
|
|
2017
Q4 | $24.5K | Buy |
+1,000
| New | +$24.5K | ﹤0.01% | 1262 |
|